ClinicalTrials.Veeva

Menu

Diaphragmatic Breathing and Stimulation of the Autonomic Nervous System

U

University of Jaén

Status

Not yet enrolling

Conditions

Healthy Adult Male and Female Volunteers

Treatments

Procedure: Breathing education
Procedure: Guided breathing at 6 breaths per minute (bpm) with an inspiration (I) to expiration (E)
Procedure: Guided breathing at 6 bpm with apnea (A)

Study type

Interventional

Funder types

Other

Identifiers

NCT07445113
DB and ANS

Details and patient eligibility

About

Introduction:

Slow, deep breathing has demonstrated beneficial effects on the autonomic nervous system, particularly by increasing parasympathetic activity through vagal nerve modulation. Previous studies suggest that this breathing pattern optimizes the sympathovagal balance, modifies physiological parameters such as heart rate, blood pressure, and oxygen saturation, and influences variables including heart rate variability (HRV) and RR intervals.

Objectives:

To analyze the effects of different slow deep breathing (SDB) training modalities on vagal tone regulation. Secondary objectives include evaluating their impact on heart rate and rhythm, HRV, cardiac beat intervals, blood pressure, and oxygen saturation.

Methodology:

A randomized, controlled, single-blind, parallel-design clinical trial will be conducted. Sixty healthy participants will be enrolled and allocated into three groups: two experimental groups (SDB with and without apnea) and one control group (breathing education). Pre- and post-intervention measurements will include HRV, RR intervals, heart rate, blood pressure, oxygen saturation, and cervical joint variables. Data will be analyzed using repeated-measures ANOVA and statistical tests appropriate for each variable type, with a significance level set at 5%.

Expected Results:

SDB-based interventions are expected to produce significant improvements in vagal regulation, increasing heart rate variability and favorably modifying the aforementioned physiological parameters compared with the control group.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy individuals who have not smoked during the 24 hours prior to the study.
  • Healthy individuals who have not drunk alcohol during the 24 hours prior to the study.
  • Healthy individuals who have not drunk coffee during the 24 hours prior to the study.

Exclusion criteria

  • Individuals with cardiovascular diseases or neurological disorders.
  • Individuals with cognitive impairment.
  • Individuals taking medications that affect autonomic nervous system function, such as: benzodiazepines, beta-blockers or beta-adrenergic agents.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 3 patient groups, including a placebo group

Experimental Group 1. SDB 6x 6
Experimental group
Description:
Guided breathing at 6 breaths per minute (bpm) with an inspiration (I) to expiration (E) ratio of 1:1
Treatment:
Procedure: Guided breathing at 6 bpm with apnea (A)
Experimental Group 2. SDB 6x6x6
Experimental group
Description:
Guided breathing at 6 bpm with apnea (A) and an I:E:A ratio of 1:1:1.
Treatment:
Procedure: Guided breathing at 6 breaths per minute (bpm) with an inspiration (I) to expiration (E)
Control Group
Placebo Comparator group
Description:
Breathing education
Treatment:
Procedure: Breathing education

Trial contacts and locations

1

Loading...

Central trial contact

Ana Sedeño Vidal, Full time professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems